Janus Henderson Group PLC Intra Cellular Therapies, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 42,729 shares of ITCI stock, worth $3.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,729
Previous 40,161 6.39%
Holding current value
$3.57 Million
Previous $2.75 Million 13.6%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $174,598 - $207,597
2,568 Added 6.39%
42,729 $3.12 Million
Q2 2024

Aug 14, 2024
SELL
$64.76 - $79.84 $23.4 Million - $28.8 Million
-361,196 Reduced 89.99%
40,161 $2.75 Million
Q1 2024

May 15, 2024
SELL
$64.37 - $75.65 $5.65 Million - $6.64 Million
-87,780 Reduced 17.95%
401,357 $27.8 Million
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $411,023 - $652,833
8,864 Added 1.85%
489,137 $35 Million
Q3 2023

Nov 14, 2023
SELL
$52.09 - $64.1 $6.81 Million - $8.37 Million
-130,642 Reduced 21.38%
480,273 $25 Million
Q2 2023

Aug 14, 2023
SELL
$54.67 - $66.44 $8.95 Million - $10.9 Million
-163,625 Reduced 21.13%
610,915 $38.7 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $21.4 Million - $27.8 Million
487,851 Added 170.17%
774,540 $41.9 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $2.64 Million - $3.26 Million
59,948 Added 26.44%
286,689 $15.2 Million
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $1.65 Million - $2.32 Million
38,690 Added 20.57%
226,741 $10.5 Million
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $2.63 Million - $4.01 Million
61,050 Added 48.07%
188,051 $10.7 Million
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $808,310 - $1.3 Million
-20,865 Reduced 14.11%
127,001 $7.77 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $59,875 - $90,867
1,701 Added 1.16%
147,866 $7.73 Million
Q3 2021

Nov 16, 2021
BUY
$28.72 - $42.49 $404,377 - $598,259
14,080 Added 10.66%
146,165 $5.45 Million
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $435,456 - $661,359
14,862 Added 12.68%
132,085 $5.39 Million
Q1 2021

May 17, 2021
BUY
$30.8 - $39.51 $2.17 Million - $2.78 Million
70,440 Added 150.57%
117,223 $3.98 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $1.09 Million - $1.51 Million
46,783 New
46,783 $1.49 Million
Q4 2017

Feb 09, 2018
SELL
$14.27 - $16.79 $499,450 - $587,650
-35,000 Closed
0 $0
Q2 2017

Aug 17, 2017
BUY
N/A
35,000
35,000 $435,000

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.88B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email